| Prateek Juneja, | |
|
1505 W Sherman Ave, Vineland, NJ 08360-7059 | |
| (856) 641-8000 | |
| Not Available |
| Full Name | Prateek Juneja |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Critical Care Medicine |
| Location | 1505 W Sherman Ave, Vineland, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962996330 | NPI | - | NPPES |
| Entity Name | Community Health Care, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700816816 PECOS PAC ID: 9335040419 Enrollment ID: O20040402000981 |
News Archive
LifeVantage Corporation, the maker of Protandim®, a clinically proven, science-based therapy for oxidative stress, announced today that a new peer-reviewed study involving Protandim® was published in the scientific journal PLoS ONE. The study, conducted by researchers at Louisiana State University, examined the biochemical mechanisms that underlie the ability of Protandim® to suppress tumors in mice. That ability was previously demonstrated by the authors in a study involving a mouse two-stage model of chemically-induced skin cancer.
African American women undergoing mastectomy for breast cancer are more likely than white women to undergo autologous breast reconstruction using their own tissue, rather than implant-based reconstruction, reports a study in the August issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).
Dexcom, Inc., a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that the U.S. Food and Drug Administration has approved the Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System.
Can skin cancer be treated with light? Scientists at the University of California, Irvine (UC Irvine), believe so. They're exploring new ways to image cancerous lesions using LEDs that might advance a technique for treating cancer called photodynamic therapy (PDT) - work that they will describe at the Optical Society's (OSA) 94th annual meeting, Frontiers in Optics (FiO) 2010 at the Rochester Riverside Convention Center in Rochester, N.Y., from Oct. 24-28.
Today, the U.S. Food and Drug Administration announced that it has awarded six new clinical trial research grants to principal investigators from academia and industry totaling over $16 million over the next four years.
› Verified 5 days ago
| Entity Name | Cmc Department Of Medicine Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679605554 PECOS PAC ID: 2163335878 Enrollment ID: O20050203000280 |
News Archive
LifeVantage Corporation, the maker of Protandim®, a clinically proven, science-based therapy for oxidative stress, announced today that a new peer-reviewed study involving Protandim® was published in the scientific journal PLoS ONE. The study, conducted by researchers at Louisiana State University, examined the biochemical mechanisms that underlie the ability of Protandim® to suppress tumors in mice. That ability was previously demonstrated by the authors in a study involving a mouse two-stage model of chemically-induced skin cancer.
African American women undergoing mastectomy for breast cancer are more likely than white women to undergo autologous breast reconstruction using their own tissue, rather than implant-based reconstruction, reports a study in the August issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).
Dexcom, Inc., a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that the U.S. Food and Drug Administration has approved the Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System.
Can skin cancer be treated with light? Scientists at the University of California, Irvine (UC Irvine), believe so. They're exploring new ways to image cancerous lesions using LEDs that might advance a technique for treating cancer called photodynamic therapy (PDT) - work that they will describe at the Optical Society's (OSA) 94th annual meeting, Frontiers in Optics (FiO) 2010 at the Rochester Riverside Convention Center in Rochester, N.Y., from Oct. 24-28.
Today, the U.S. Food and Drug Administration announced that it has awarded six new clinical trial research grants to principal investigators from academia and industry totaling over $16 million over the next four years.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Prateek Juneja, 1 Federal St Ste 200, Camden, NJ 08103-1088 Ph: (848) 288-6935 | Prateek Juneja, 1505 W Sherman Ave, Vineland, NJ 08360-7059 Ph: (856) 641-8000 |
News Archive
LifeVantage Corporation, the maker of Protandim®, a clinically proven, science-based therapy for oxidative stress, announced today that a new peer-reviewed study involving Protandim® was published in the scientific journal PLoS ONE. The study, conducted by researchers at Louisiana State University, examined the biochemical mechanisms that underlie the ability of Protandim® to suppress tumors in mice. That ability was previously demonstrated by the authors in a study involving a mouse two-stage model of chemically-induced skin cancer.
African American women undergoing mastectomy for breast cancer are more likely than white women to undergo autologous breast reconstruction using their own tissue, rather than implant-based reconstruction, reports a study in the August issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).
Dexcom, Inc., a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that the U.S. Food and Drug Administration has approved the Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System.
Can skin cancer be treated with light? Scientists at the University of California, Irvine (UC Irvine), believe so. They're exploring new ways to image cancerous lesions using LEDs that might advance a technique for treating cancer called photodynamic therapy (PDT) - work that they will describe at the Optical Society's (OSA) 94th annual meeting, Frontiers in Optics (FiO) 2010 at the Rochester Riverside Convention Center in Rochester, N.Y., from Oct. 24-28.
Today, the U.S. Food and Drug Administration announced that it has awarded six new clinical trial research grants to principal investigators from academia and industry totaling over $16 million over the next four years.
› Verified 5 days ago
Dr. Antonio Quiachon Velasco Jr., D.O. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1138 E Chestnut Ave Ste 8b, Vineland, NJ 08360 Phone: 856-213-9733 Fax: 856-575-5080 | |
Natasha J Shah, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2950 College Dr, Vineland, NJ 08360 Phone: 866-600-2273 | |
Narasimhaloo Venugopal, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 1100 E Chestnut Ave, Vineland, NJ 08360 Phone: 856-696-0108 Fax: 856-696-0188 | |
Teodulo M Mendoza, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 1676 E Landis Ave, Vineland, NJ 08361 Phone: 856-696-6431 Fax: 856-794-5803 | |
Dr. Justyna Obara, Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 785 W Sherman Ave, Vineland, NJ 08360 Phone: 856-451-4700 | |
David Seth Shields, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2950 College Dr, Suite 2a, Vineland, NJ 08360 Phone: 856-691-1129 Fax: 856-691-1229 | |
Dr. Carina P. Sayo-lim, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 524 N West Blvd, Vineland, NJ 08360 Phone: 856-405-4296 Fax: 856-794-5712 |